Comprehensive cost and utilization of commercial CAR-T therapy in pediatric B-ALL patients

FHS
May 17, 2024
8:05 pm

A new editorial paper was published in Oncoscience (Volume 11) on April 25, 2024, entitled, “The price of hope: CAR-T therapy in pediatric leukemia.”

In setback, Pfizer abandons one weight-loss pill and bets on another

Pfizer said Monday that it had discontinued clinical trials of a once-daily weight-loss pill whose results were highly anticipated by investors because patients taking the

June 26, 2023

Adding Regorafenib in First-Line ‘Promising’ in Gastric Cancer

Adding regorafenib (Stivarga) to a standard first-line chemoimmunotherapy regimen for HER2-negative metastatic esophagogastric cancer demonstrated “promising” activity in a single-arm phase II study, according to

September 6, 2023

Mini intestines uncover mechanisms behind COVID-19-related diarrhea and potential treatments

Working with human stem cells that form a kind of “mini intestine-in-a-dish,” Johns Hopkins Medicine scientists say they have found several molecular mechanisms for COVID-19-related

August 6, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.